Mitral Valve Regurgitation After Lung Transplantation: Aetiology, Management and Outcome

2021 ◽  
Author(s):  
William Y. Shi ◽  
Jason E. Bloom ◽  
Rong Shen ◽  
Bronwyn J. Levvey ◽  
Antony S. Walton ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Lung Transplantation ◽  
Mitral Valve Regurgitation ◽  
Valve Regurgitation

Progression of Mitral Valve Regurgitation after Lung Transplantation

2019 ◽  
Vol 38 (4) ◽  
pp. S326
Author(s):  
W.Y. Shi ◽  
B. Levvey ◽  
A.D. Zimmet ◽  
S.F. Marasco ◽  
G. Snell ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Lung Transplantation ◽  
Mitral Valve Regurgitation ◽  
Valve Regurgitation

A new device to treat mitral valve regurgitation: a proof of concept in bench test study

2021 ◽  
Vol 45 (3) ◽  
pp. 197-206
Author(s):  
Giovanni Alfonso Chiariello ◽  
Saimir Kuci ◽  
Guglielmo Saitto ◽  
Massimo Massetti ◽  
Ottavio Alfieri ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Mitral Valve Regurgitation ◽  
Bench Test ◽  
Proof Of Concept ◽  
Valve Regurgitation ◽  
New Device ◽  
Test Study

scholarly journals Sequential Venous Percutaneous Transluminal Angioplasty and Balloon Dilatation of the Interatrial Septum during Percutaneous Edge-to-Edge Mitral Valve Repair

2017 ◽  
Vol 2017 ◽  
pp. 1-3
Author(s):  
Rezo Jorbenadze ◽  
Johannes Patzelt ◽  
Meinrad Gawaz ◽  
Peter Seizer ◽  
Harald F. Langer
Keyword(s):  
Mitral Valve ◽  
Mitral Valve Repair ◽  
Percutaneous Transluminal Angioplasty ◽  
Balloon Dilatation ◽  
Mitral Valve Regurgitation ◽  
Interatrial Septum ◽  
Transluminal Angioplasty ◽  
Valve Regurgitation ◽  
Valve Repair ◽  
Percutaneous Transluminal

Percutaneous edge-to-edge mitral valve repair (PMVR) is widely used for selected, high-risk patients with severe mitral valve regurgitation (MR). This report describes a case of 81-year-old woman presenting with severe and highly symptomatic mitral valve regurgitation (MR) caused by a flail of the posterior mitral valve leaflet (PML). PMVR turned out to be challenging in this patient because of a stenosis and tortuosity of both iliac veins as well as sclerosis of the interatrial septum, precluding the vascular and left atrial access by standard methods, respectively. We managed to achieve atrial access by venous percutaneous transluminal angioplasty (PTA) and balloon dilatation of the interatrial septum. Subsequently, we could advance the MitraClip® system to the left atrium, and deployment of the clip in the central segment of the mitral valve leaflets (A2/P2) resulted in a significant reduction of MR.

Sign in / Sign up

Export Citation Format

Share Document